Table 4.
PL | GTE | Time | Treatment | Time × treatment | |
---|---|---|---|---|---|
Total antioxidant capacity (TAC) (mmol/L) | |||||
Rest | 1.33 ± 0.04 | 1.52 ± 0.03‡ | Yes | Yes | Yes |
5 min | 1.58 ± 0.04*** | 1.54 ± 0.04 | |||
24 h | 1.51 ± 0.05** | 1.59 ± 0.06 | |||
Uric acid (UA) (mg/dL) | |||||
Rest | 5.15 ± 0.26 | 4.31 ± 0.20 | Yes | No | No |
5 min | 5.16 ± 0.26 | 4.30 ± 0.15 | |||
24 h | 6.61 ± 0.29***, ††† | 6.81 ± 0.28***, ††† | |||
Albumin (AL) (g/dL) | |||||
Rest | 4.09 ± 0.14 | 4.06 ± 0.10 | Yes | No | No |
5 min | 4.68 ± 0.18** | 4.89 ± 0.20*** | |||
24 h | 4.20 ± 0.08† | 4.44 ± 0.14† | |||
Superoxide dismutase (SOD) (U/g Hb) | |||||
Rest | 1,596.8 ± 55.7 | 1,524.0 ± 28.4 | Yes | Yes | Yes |
5 min | 1,797.4 ± 33.9*** | 1,497.2 ± 32.5‡‡‡ | |||
24 h | 1,794.3 ± 34.3*** | 1,468.8 ± 25.8‡‡‡ | |||
Glutathione peroxidase (GPx) (U/g Hb) | |||||
Rest | 46.8 ± 2.2 | 39.0 ± 2.1 | No | No | No |
5 min | 38.8 ± 1.7 | 37.1 ± 1.1 | |||
24 h | 38.3 ± 3.2 | 37.8 ± 1.9 | |||
Malondialdehyde (MDA) (µmol/L) | |||||
Rest | 1.15 ± 0.09 | 0.66 ± 0.04‡ | Yes | Yes | No |
5 min | 1.48 ± 0.08** | 0.85 ± 0.06‡‡ | |||
24 h | 0.86 ± 0.09††† | 0.53 ± 0.02†† | |||
Creatine kinase (CK) (U/L) | |||||
Rest | 192.0 ± 18.2 | 178.1 ± 15.0 | Yes | No | No |
5 min | 219.5 ± 18.9 | 199.0 ± 17.2 | |||
24 h | 230.6 ± 21.5* | 231.5 ± 19.8** |
Values are presented as mean ± SEM. Blood samples were collected before the test (at rest), 5 min after the test (5 min), and after 24 h of recovery (24 h). The data were analyzed using two-way ANOVA: two treatment (placebo and GTE) × three time points (at rest, 5 min, and 24 h after completion of the test)
*, **, *** Significantly different (p < 0.05; p < 0.01; p < 0.001, respectively) from the resting value (within the same treatment; Bonferroni test)
††, †††Significantly different (p < 0.01; p < 0.001, respectively) from the value determined at 5 min (within the same treatment; Bonferroni test)
‡, ‡‡, ‡‡‡Significantly different (p < 0.05; p < 0.01; p < 0.001, respectively) from the respective value determined after placebo treatment (Bonferroni test)